AEZS-108 and doxorubicin in patients with endometrial cancer

• Research type

  Research Study

• Full title

  Randomised controlled study comparing AEZS-108 with doxorubicin as second line therapy for locally advanced, recurrent or metastatic endometrial cancer

• IRAS ID

  134115

• Contact name

  Hani Gabra

• Contact email

  h.gabra@imperial.ac.uk

• Sponsor organisation

  Aeterna Zentaris GmbH

• Eudract number

  2012-005546-38

• ISRCTN Number

  0

• REC name

  Wales REC 3

• REC reference

  13/WA/0328

• Date of REC Opinion

  17 Oct 2013

• REC opinion

  Further Information Favourable Opinion